Grifols

Grifols is a multinational healthcare firm that has worked to promote the health and well-being of people all over the world since its founding in Barcelona in 1909. In more than 100 countries and territories, our four businesses - Bioscience, Diagnostics, Hospital, and Bio Supplies - create, produce, and sell new medicines, solutions, and services.

They are one of the major plasma firms, with a growing network of donation sites throughout the world, as a pioneer in the blood products market. They make important medications using the plasma they collect to treat chronic, uncommon, and sometimes life-threatening disorders. They have a complete array of products designed to assure safety from donor to transfusion as a recognized leader in transfusion medicine. They also give diagnostic instruments and services to hospitals, pharmacies, and healthcare professionals to aid in the identification and treatment of illnesses, fostering specialized and efficient care.

Grifols is devoted to a sustainable business strategy and is a pioneer in continuous innovation, quality, safety, and ethical leadership in the healthcare industry, with over 24,000 people in more than 30 countries and regions. Their activities have a good social and economic impact in the nations where they operate, resulting in the creation of employment and money.

Founded: November 18, 1940

Headquarters: Barcelona, Spain
Market Cap: 14.181 Billion USD
Website: https://www.grifols.com/en/home